Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • antigen

Tag: antigen

  • BiotechToday
  • World

LEAD: A low-cost Covid testing method using pencil graphite

BioTech Today August 19, 2021August 19, 2021 3

Sayak Banerjee, Amity University Kolkata COVID-19 has already taken over 4 million lives around the world, hence testing is essential for understanding the virus and controlling its spread. Currently, the tests are restricted by two factors, time taken and the accuracy required for analyzing a sample. The third factor which poses a challenge towards the […]

Read More
  • Biotechnopedia
  • DNA-Tales

Goodpasture Syndrome- A Condition affecting One in every Million

DNA tales August 12, 2021August 12, 2021 2

Priasha Dutta, Amity University Kolkata, West Bengal A very rare and life-threatening autoimmune disease, Goodpasture syndrome (GPS) was discovered in 1919 by Dr. Ernest Goodpasture when he reported a case of bleeding in the lungs and glomerulonephritis during an influenza epidemic. Its rate of occurrence is 1 out of 1 million per year. This disorder […]

Read More
  • BiotechToday
  • India

Coviself: Covid-19 home testing kit approved by ICMR

bioxone May 20, 2021May 20, 2021 2

Aakancha Shaw, St. Xavier’s College, Kolkata On Wednesday, the ICMR issued an advisory for the use of a home testing kit for Covid-19. This home testing kit is the rapid antigen testing kit developed and validated by Mylab Discovery Solutions, named “Coviself Covid19 OTC Antigen LF device”. Drugs Controller General of India (DCGI) has also […]

Read More
  • Biotechnopedia
  • DNA-Tales

CAR-T FOR CARCINOMA- THE GAME CHANGER IN CANCER TREATMENT

bioxone November 23, 2020November 23, 2020 1

PRIASHA DUTTA, AMITY UNIVERSITY KOLKATA, WEST BENGAL One of the leading causes of mortality in the present-day world is cancer. Whenever we think of cancer treatment, the two words that are immediately synonymous are chemotherapy and radiation therapy. Although, due to limited efficacy based on the heterogeneity factor of cancer cells, there is a constant […]

Read More
  • BiotechToday
  • World

Convalescent Plasma Therapy – Promising need of the Hour!

bioxone October 10, 2020October 10, 2020

-Raddur Samaddar, Team bioXone While the world is waiting for a COVID-19 vaccine with absolute eagerness, the closest promising immunological treatment that can help stop the rate of the ever-increasing spread of the SARS-CoV-2 virus is the Convalescent Plasma Therapy. This treatment relies upon the transfusion of the anti-viral antibodies from donors to recipients with […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020 1

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Read More
  • World

A unique class of T cells may improve immunotherapeutic treatments

bioxone September 27, 2020September 27, 2020

-Binayak Das, Team Bioxone A new study has revealed the presence of a unique class of T cells, known as the Memory CD8 T lymphocytes, in mice, and its analogous population in humans also. This class of memory cells exhibited combined molecular functioning characteristic features, of both short-lived effector cells and long-lived memory T cells. […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy